Injections, Subcutaneous

"Injections, Subcutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin.

Descriptor ID	D007279
MeSH Number(s)	E02.319.267.530.620
Concept/Terms	Injections, Subcutaneous Injections, Subcutaneous Subcutaneous Injections Injection, Subcutaneous Subcutaneous Injection

Below are MeSH descriptors whose meaning is more general than "Injections, Subcutaneous".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Injections [E02.319.267.530]
Injections, Subcutaneous [E02.319.267.530.620]

Below are MeSH descriptors whose meaning is related to "Injections, Subcutaneous".

Below are MeSH descriptors whose meaning is more specific than "Injections, Subcutaneous".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Injections, Subcutaneous" by people in this website by year, and whether "Injections, Subcutaneous" was a major or minor topic of these publications.

Bar chart showing 55 publications over 25 distinct years, with a maximum of 4 publications in 1996 and 2005 and 2006 and 2007 and 2009 and 2010

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
1994	1	1
1996	4	4
1997	1	1
1998	1	1
1999	1	1
2001	1	1
2002	2	2
2003	3	3
2004	2	2
2005	4	4
2006	4	4
2007	4	4
2008	2	2
2009	4	4
2010	4	4
2011	1	1
2012	1	1
2013	2	2
2015	1	1
2016	1	1
2017	2	2
2018	3	3
2019	3	3
2021	2	2
2022	1	1

Below are the most recent publications written about "Injections, Subcutaneous" by people in Profiles.

Rubino DM, Greenway FL, Khalid U, O'Neil PM, Rosenstock J, Sørrig R, Wadden TA, Wizert A, Garvey WT. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022 01 11; 327(2):138-150.

View in: PubMed
Scott ES, Januszewski AS, Carroll LM, Fulcher GR, Joglekar MV, Hardikar AA, Jones TW, Davis EA, Jenkins AJ. Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes. Sci Rep. 2021 08 17; 11(1):16656.

View in: PubMed
Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, Lingvay I, O'Neil PM, Rubino DM, Skovgaard D, Wallenstein SOR, Garvey WT. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021 04 13; 325(14):1403-1413.

View in: PubMed
Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA. 2019 07 23; 322(4):326-335.

View in: PubMed
Steg PG, Szarek M, Bhatt DL, Bittner VA, Brégeault MF, Dalby AJ, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Ostadal P, Parkhomenko A, Pordy R, Roe MT, Tricoci P, Vogel R, White HD, Zeiher AM, Schwartz GG. Effect of Alirocumab on Mortality After Acute Coronary Syndromes. Circulation. 2019 07 09; 140(2):103-112.

View in: PubMed
Peebles ED, Cummings TS, Barbosa TM, Wilson FD, Williams CJ, Gerard PD. Comparative effects of in ovo versus subcutaneous administration of the Marek's disease vaccine and pre-placement holding time on the intestinal villus to crypt ratios of Ross 708 broilers during early post-hatch development1,2,3. Poult Sci. 2019 Feb 01; 98(2):712-716.

View in: PubMed
Jacob S, Nichols J, Macdougall IC, Qureshi Z, Chen B, Yang YT, Norris LB, Bennett CL. Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the "ANTICIPATE" Framework. Am J Ther. 2018 Nov/Dec; 25(6):e670-e674.

View in: PubMed
O'Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, Carson CG, Jepsen CH, Kabisch M, Wilding JPH. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018 08 25; 392(10148):637-649.

View in: PubMed
Harrison SA, Abdelmalek MF, Caldwell S, Shiffman ML, Diehl AM, Ghalib R, Lawitz EJ, Rockey DC, Schall RA, Jia C, McColgan BJ, McHutchison JG, Subramanian GM, Myers RP, Younossi Z, Ratziu V, Muir AJ, Afdhal NH, Goodman Z, Bosch J, Sanyal AJ. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. Gastroenterology. 2018 10; 155(4):1140-1153.

View in: PubMed
Peebles ED, Barbosa TM, Cummings TS, Dickson J, Womack SK, Gerard PD. Comparative effects of in ovo versus subcutaneous administration of the Marek's disease vaccine and pre-placement holding time on the processing yield of Ross 708 broilers. Poult Sci. 2017 Sep 01; 96(11):3944-3948.

View in: PubMed

People

Explore

Similar Concepts

Top Journals